Retrospective stratified analysis of resistance mechanisms to anti-EGFR therapy in mCRC using tumor tissue samples
Abstract The aim of this study was to investigate the mechanisms of acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC), with a focus on the role of KRAS secondary mutations. We sought to evaluate how these mutations contribute to resist...
Saved in:
| Main Authors: | Xueming Xia, Wei Du, Qiheng Gou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-03684-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study
by: Nurullah Ilhan, et al.
Published: (2025-04-01) -
Molecular symphonies and signalling pathways orchestrated by the gut microbiome in metastatic colorectal cancer (mCRC); a state-of-the-art review
by: Nayeralsadat Fatemi, et al.
Published: (2024-01-01) -
MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T
by: A. O. Ivantsov, et al.
Published: (2016-04-01) -
Heterogeneity and clonal evolution of colorectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2017-04-01) -
The impact of KRAS mutations on risk of venous thromboembolism recurrence in patients with metastatic colorectal cancer
by: Zhikun Liang, et al.
Published: (2025-04-01)